Determining the Structure and Function of Newly Discovered Immune Systems

Information

  • Research Project
  • 10227177
  • ApplicationId
    10227177
  • Core Project Number
    R35GM138080
  • Full Project Number
    5R35GM138080-02
  • Serial Number
    138080
  • FOA Number
    PAR-17-190
  • Sub Project Id
  • Project Start Date
    8/1/2020 - 4 years ago
  • Project End Date
    5/31/2025 - a month ago
  • Program Officer Name
    BENDER, MICHAEL T
  • Budget Start Date
    6/1/2021 - 4 years ago
  • Budget End Date
    5/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    5/19/2021 - 4 years ago
Organizations

Determining the Structure and Function of Newly Discovered Immune Systems

Project Summary Basic research on newly discovered immune systems has led to the development of important molecular tools for use in science and medicine. For example, eukaryotic antibodies are used to diagnose and treat disease, prokaryotic restriction enzymes are used to manipulate DNA sequences in vitro, and prokaryotic CRISPR-Cas adaptive immune systems are revolutionizing genome editing, gene therapy, and disease diagnostics. Recently, several new immune systems have been discovered for which their function remains unknown. The emphasis of this proposal is to determine the structure and function of two newly discovered CRISPR-Cas adaptive immune systems with the primary objectives to (i.) fill gaps in our understanding of these biological systems and (ii) provide the basic mechanistic knowledge necessary to develop these immune systems into new life science tools. To better understand the function of these immune systems we are using cell-based and biochemical assays, as well as structural methods such x-ray crystallography and cryo-EM. We hope to determine how these systems identify their targets, how they distinguish self from non-self, and how their distinct genetic differences (protein domains and genes) impact their function. !

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R35
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    115000
  • Total Cost
    365000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIGMS:365000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UTAH STATE UNIVERSITY
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    072983455
  • Organization City
    LOGAN
  • Organization State
    UT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    843221415
  • Organization District
    UNITED STATES